$ALVR

AlloVir Inc

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$4.22 β–Ό-1.171%

Extented Hours

VOLUME

1,271,151

DAY RANGE

4.19 - 4.53

52 WEEK

3.17 - 26.41

Join Discuss about ALVR with like-minded investors

profile
@singletary #StockTraders.NET
recently

$alvr will watch at close. $sev as well

125 Replies 11 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

watchlist tomorrow: $SEV, $MDVL, $ATER, $LLAP, $ALVR, $CRXT

50 Replies 13 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

covered some more $ALVR

61 Replies 9 πŸ‘ 13 πŸ”₯

KC
@KCj #StockTraders.NET
recently

For some reason, the $CRXT move just looked clearer, where the $ALVR seemed choppy and right off the open, and more like day 1 stuff I'm afraid to touch.

115 Replies 8 πŸ‘ 6 πŸ”₯

KC
@KCj #StockTraders.NET
recently

Thanks for the chart/tips on $ALVR @maletone

149 Replies 9 πŸ‘ 7 πŸ”₯

profile
@Chano #StockTraders.NET
recently

in ALVR around 10 it didn't break VWAP, I am sure someone got squeezed there (the stock had 12% short float to start with)

62 Replies 8 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$alvr about to get more covers

63 Replies 12 πŸ‘ 9 πŸ”₯

KC
@KCj #StockTraders.NET
recently

@chano 11:30 on the $CRXT parabolic push, but $ALVR right around 10.

118 Replies 10 πŸ‘ 14 πŸ”₯

KC
@KCj #StockTraders.NET
recently

Question maybe for @maletone, but anyone really. I get the $CRXT parabolic trade, seeing it ramp up w/ volume and blow a top. But I don't get $ALVR this morning. Tips on how to look at the day one gapper and judge risk? It ramps from the open with high volume, but seems harder to tell when it's going to let up...

149 Replies 10 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$ALVR just wow

127 Replies 11 πŸ‘ 8 πŸ”₯

profile
@singletary #StockTraders.NET
recently

feel like no one going to be left after this $veru $ater $crxt $alvr $mdvl

56 Replies 7 πŸ‘ 8 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$alvr more

58 Replies 11 πŸ‘ 8 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$ALVR on watch

61 Replies 7 πŸ‘ 6 πŸ”₯

profile
@Chano #StockTraders.NET
recently

oooh my! $ALVR

72 Replies 15 πŸ‘ 9 πŸ”₯

profile
@maletone #StockTraders.NET
recently

covered some $ALVR

101 Replies 15 πŸ‘ 12 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ALVR is the only one I see has potential for dumb skipping action later today

110 Replies 14 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$ALVR close

44 Replies 12 πŸ‘ 15 πŸ”₯

profile
@singletary #StockTraders.NET
recently

like Nate's idea on $alvr havnt had a algo walk mid day yet.

71 Replies 8 πŸ‘ 10 πŸ”₯

profile
@maletone #StockTraders.NET
recently

might steal some attention from $ALVR

120 Replies 9 πŸ‘ 10 πŸ”₯

profile
@singletary #StockTraders.NET
recently

Yupp moved on flat on it. focus $alvr

113 Replies 10 πŸ‘ 10 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$alvr 7.3 is the lvl for me later today until higher lvl

57 Replies 8 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

covered some $ALVR\

52 Replies 7 πŸ‘ 10 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$io $sev $ater $veru charts all pulled up beside each other. fucking sexy. thank you for $alvr (first stuff there)

49 Replies 6 πŸ‘ 13 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

9.30 - 9.5 key lvls if it can get there $ALVR

90 Replies 14 πŸ‘ 15 πŸ”₯

profile
@singletary #StockTraders.NET
recently

should be use to the algo by now. so be patient $alvr

135 Replies 11 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$ALVR nice I was small

140 Replies 8 πŸ‘ 12 πŸ”₯

Key Metrics

Market Cap

295.03 M

Beta

1.74

Avg. Volume

437.61 K

Shares Outstanding

65.42 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-05

Next Dividend Date

Company Information

AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir’s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.

Website:

HQ: ,

Related News